The tweet was deleted by the author.
But we saved everything 🙂.
Stereotaxis, Inc. is set to present its newest advancements in robotic electrophysiology at the upcoming EHRA2026 conference in Paris.
The company aims to demonstrate cutting-edge technologies at their booth, inviting attendees to explore the transformative potential of robotic cardiology procedures. Stereotaxis, Inc.'s participation underscores their ongoing commitment to innovation within cardiac care and medical robotics.
The company previously promoted its RoboticEP platform as a solution to reduce radiation exposure for patients and doctors during procedures, according to a company statement. Stereotaxis has also offered an interactive online demonstration to showcase the platform’s capabilities. These initiatives coincide with Stereotaxis' efforts to expand the adoption of robotic technologies in cardiology.